Finance

Lists
002873:SHE
Guiyang Xintian Pharmaceutical Co Ltd
CNÂ¥7.95
+0.63%
(+0.050) 1D
Aug 7, 12:17:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002873...
Open
CNÂ¥7.85
High
CNÂ¥7.97
Low
CNÂ¥7.77
Mkt. cap
1.90B
Avg. vol.
8.06M
Volume
4.94M
Dividend
0.38%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
267.23
52-wk high
CNÂ¥15.19
52-wk low
CNÂ¥7.04
EPS
CNÂ¥0.03
Shares outstanding
244.10M
No. of employees
1K
Open
CNÂ¥7.85
High
CNÂ¥7.97
Low
CNÂ¥7.77
Mkt. cap
1.90B
Avg. vol.
8.06M
Volume
4.94M
Dividend
0.38%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
267.23
52-wk high
CNÂ¥15.19
52-wk low
CNÂ¥7.04
EPS
CNÂ¥0.03
Shares outstanding
244.10M
No. of employees
1K
About Guiyang Xintian Pharmaceutical Co Ltd
CEO-
Employees1.39K
FoundedAug 11, 1995
Headquarters-
SectorPharmaceutical industry
Websitegyxtyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
165.13M
200.35M
191.09M
178.61M
Cost of goods sold
48.35M
54.09M
59.09M
49.13M
Cost of revenue
48.35M
54.09M
59.09M
49.13M
Research and development expenses
10.97M
12.03M
10.41M
9.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.97M
114.04M
125.40M
106.18M
Operating expense
113.86M
130.34M
137.34M
118.71M
Total operating expenses
162.22M
184.43M
196.43M
167.84M
Operating income
2.92M
15.92M
-5.35M
10.77M
Other non operating income
151.82K
-215.68K
505.88K
-40.98K
EBT including unusual items
1.80M
10.40M
-6.90M
5.25M
EBT excluding unusual items
-846.64K
11.83M
-9.94M
6.33M
Income tax expense
219.78K
-13.00K
167.36K
1.75M
Effective tax rate
12.22%
-0.12%
-2.42%
33.37%
Other operating expenses
3.18M
5.16M
1.56M
3.83M
Net income
1.58M
10.41M
-7.07M
3.50M
Net profit margin
0.96%
5.20%
-3.70%
1.96%
Earnings per share
-
-
-
-
Interest and investment income
103.87K
84.26K
124.27K
95.66K
Interest expense
-4.02M
-3.96M
-5.23M
-4.50M
Net interest expenses
-3.92M
-3.88M
-5.10M
-4.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
11.18M
23.68M
2.87M
18.99M
Gain or loss from assets sale
845.41K
-845.41K
781.86K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps